Hederagenin Ameliorates Inferior Vena Cava Thrombosis via Modulating the MDM2-p53 Axis to Concurrently Suppress NF-κB-Mediated Endothelial Inflammation, Oxidative Stress, and Platelet Activation

Aim: The aim of this study was to investigate the antioxidant and anti-inflammatory potential of hederagenin (HD), a natural bioactive compound from the Sparganii Rhizoma–Curcumae Rhizoma herb pair, in deep vein thrombosis (DVT) and to elucidate its mechanism via the MDM2–p53 axis. Methods: A rat DVT model induced by inferior vena cava stenosis and an oxygen–glucose deprivation (OGD)-stimulated EA.hy926 endothelial cell model were established. Rats received HD (12.5, 25, 50 mg/kg) or heparin. Thrombus weight, coagulation, histopathology, immunofluorescence, immunohistochemistry, and Western blot were assessed. Inflammatory cytokines (TNF-α, IL-1β, CRP) and oxidative stress markers (SOD, MDA) were measured. Platelet aggregation was induced by ADP, arachidonic acid, and thrombin. Network pharmacology, molecular docking, and molecular dynamics simulations were performed. Results: HD dose-dependently reduced thrombus weight, improved coagulation, and downregulated tissue factor and von Willebrand factor. HD decreased TNF-α, IL-1β, CRP, and MDA levels and restored SOD activity, demonstrating antioxidant and anti-inflammatory effects. Network pharmacology identified MDM2 as a core target. Molecular docking showed favorable HD–MDM2 binding (−8.2 kcal/mol), and 100 ns molecular dynamics confirmed complex stability. HD downregulated MDM2, upregulated p53/p-p53, and suppressed NF-κB p65 phosphorylation and acetylation in IVC tissues and OGD-stimulated cells. HD also inhibited platelet aggregation, reduced vWF release, and downregulated CD41/CD61. Conclusions: HD, a natural bioactive compound, attenuates DVT through antioxidant and anti-inflammatory mechanisms by modulating the MDM2–p53 axis, concurrently suppressing endothelial inflammation, oxidative stress, and platelet activation. It is a promising dual-acting candidate for DVT therapy.

Authors

Institutions

Publication Details

Journal
Antioxidants
Published
2026-11-06
DOI
https://doi.org/10.3390/antiox15111437
Primary Topic
Traditional Chinese Medicine Analysis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hederagenin Ameliorates Inferior Vena Cava Thrombosis via Modulating the MDM2-p53 Axis to Concurrently Suppress NF-κB-Mediated Endothelial Inflammation, Oxidative Stress, and Platelet Activation

Tong Wang, 陈志豪, Xiaofan Zhang, Wei Xie et al.
Antioxidants
Traditional Chinese Medicine Analysis
article

Hederagenin Ameliorates Inferior Vena Cava Thrombosis via Modulating the MDM2-p53 Axis to Concurrently Suppress NF-κB-Mediated Endothelial Inflammation, Oxidative Stress, and Platelet Activation

Tong Wang, 陈志豪, Xiaofan Zhang, Wei Xie, Jinglei Huang, Tianzi Wang, Wenling Shi, Youqing Cheng, Xingyue Song, Lihan Song, Yan Zhang
article en

Abstract

Aim: The aim of this study was to investigate the antioxidant and anti-inflammatory potential of hederagenin (HD), a natural bioactive compound from the Sparganii Rhizoma–Curcumae Rhizoma herb pair, in deep vein thrombosis (DVT) and to elucidate its mechanism via the MDM2–p53 axis. Methods: A rat DVT model induced by inferior vena cava stenosis and an oxygen–glucose deprivation (OGD)-stimulated EA.hy926 endothelial cell model were established. Rats received HD (12.5, 25, 50 mg/kg) or heparin. Thrombus weight, coagulation, histopathology, immunofluorescence, immunohistochemistry, and Western blot were assessed. Inflammatory cytokines (TNF-α, IL-1β, CRP) and oxidative stress markers (SOD, MDA) were measured. Platelet aggregation was induced by ADP, arachidonic acid, and thrombin. Network pharmacology, molecular docking, and molecular dynamics simulations were performed. Results: HD dose-dependently reduced thrombus weight, improved coagulation, and downregulated tissue factor and von Willebrand factor. HD decreased TNF-α, IL-1β, CRP, and MDA levels and restored SOD activity, demonstrating antioxidant and anti-inflammatory effects. Network pharmacology identified MDM2 as a core target. Molecular docking showed favorable HD–MDM2 binding (−8.2 kcal/mol), and 100 ns molecular dynamics confirmed complex stability. HD downregulated MDM2, upregulated p53/p-p53, and suppressed NF-κB p65 phosphorylation and acetylation in IVC tissues and OGD-stimulated cells. HD also inhibited platelet aggregation, reduced vWF release, and downregulated CD41/CD61. Conclusions: HD, a natural bioactive compound, attenuates DVT through antioxidant and anti-inflammatory mechanisms by modulating the MDM2–p53 axis, concurrently suppressing endothelial inflammation, oxidative stress, and platelet activation. It is a promising dual-acting candidate for DVT therapy.

AntioxidantsVol. 15(11)
Shanghai University of Engineering Science (CN), Shanghai University of Medicine and Health Sciences (CN)
Shanghai Key Laboratory of Molecular Imaging
Good health and well-being
Openalex Percentile: Top 8%
Traditional Chinese Medicine Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon